摘要
目的探讨血清降钙素原(procacitonin,PCT)对患者感染诊断及其预后判断的临床价值。方法对某院2009年9月—2010年12月同时采集血液进行细菌培养与PCT检测患者的临床资料进行回顾性分析。结果 570份同时送检的标本,PCT和血培养的阳性率分别为46.49%(265/570)、30.18%(172/570);以0.50 ng/mL为界点,PCT诊断的敏感性为90.53%(516/570)、特异性为64.74%(369/570),阳性预测值和阴性预测值分别为44.53%(118/265)、82.30%(251/305)。结论定量PCT检测对患者早期感染的诊断及预后判断具有重要的指导意义,可连续监测患者感染状况,及时为临床决策提供依据。
Objective To evaluate the clinical significance of procalcitonin (PCT) for the diagnosis and prognosis of infections in patients. Methods PCT and blood culture data of patients in a hospital from September 2009 to December 2010 were analyzed retrospectively. Results Among 570 detected samples, the positive rate of PCT and blood culture was 46. 49% (265/570) and 30. 18% (172/570) respectively; when PCT = 0. 50ng/mL was used as the cut-off value of diagnosis, the sensitivity and specificity of PCT was 90. 53%(516/570)and 64. 74% (369/570) respectively, the positive and negative predictive value of PCT was 44. 53% (118/265)and 82. 30% (251/305) re- spectively. Conclusion Quantitative PCT has important guiding significance for the early diagnosis and prognosis e- valuation of infections in patients, it can provide evidence for clinical decision-making by continuously monitoring in- fections in patients.
出处
《中国感染控制杂志》
CAS
2012年第3期189-191,共3页
Chinese Journal of Infection Control
关键词
降钙素原
感染
诊断
预后
病原菌
血培养
procalcitonin
infectiom diagnosis
prognosis
pathogenl blood culture